Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Histone deacetylase class I and class IIa are two subfamilies of histone deacetylase enzymes (HDACs), which remove acetyl groups from lysine residues on histone and non-histone proteins, leading to chromatin condensation and transcriptional repression. Class I HDACs (HDAC1, 2, 3, 8) are mostly nuclear, have robust deacetylase activity, and are key regulators of gene expression and cell proliferation. Class IIa HDACs (HDAC4, 5, 7, 9) shuttle between the nucleus and cytoplasm, act primarily as signal-dependent transcriptional repressors, and have limited intrinsic deacetylase activity due to a key amino acid substitution in their active site, but operate mainly by recruiting class I HDACs and interacting with transcription factors (such as MEF2). Both classes are involved in epigenetic regulation, cellular differentiation, metabolism, and are targets for anticancer and other therapeutics. Important note on naming: "Histone deacetylase class I/IIa" designates two parallel subfamilies, not a singular molecule. For structured data, list individual enzymes (e.g., HDAC1, HDAC2, HDAC4, HDAC5, etc.) as specific targets.
Inhibition of deacetylase enzymatic activity, leading to increased acetylation of histones and non-histone proteins. Transcriptional activation of tumor suppressor genes due to chromatin relaxation. Alteration of protein–protein interactions (e.g., between HDACs and transcription factors/co-repressors).
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Histone deacetylase class I and class IIa (HDAC class I/IIa).